|The Nano Science and Technology Institute and National Cancer Institute create a symposium of experts to address challenges for cancer research|
NEW YORK (February 2, 2005): The Nano Science and Technology Institute (NSTI) and the National Cancer Institute (NCI) have teamed up, along with Northeastern University, to create a symposium of experts to address the challenges of cancer research and treatment. The NCI-NSTI Nanotechnology for Cancer Special Symposium on Nanotechnology for Cancer Prevention, Diagnosis, and Treatment, will take place alongside NSTI’s Nanotech and Bio Nano Conferences in May of 2005.
“By collaborating with the National Cancer Institute, we aim to engage in efforts to harness the power of nanotechnology to radically change the way we diagnose, image and treat cancer. Nanotechnology has the potential to have a revolutionary impact on cancer diagnosis and therapy”, says Dr. Matthew Laudon, spokesperson for NSTI.
“A major challenge in cancer diagnosis in the 21st century is to be able to determine the exact relationship between cancer biomarkers and clinical pathology, as well as, to be able to non-invasively detect tumors at an early stage for maximum therapeutic benefit”, says symposium chair Srinivas Sridhar of Northeastern University. “In cancer therapy, targeting and localized delivery are the key challenges, and this symposium will address the potential ways in which nanotechnology can address these challenges.”
Topics and applications for Nanotechnology for Cancer Prevention, Diagnosis, and Treatment Symposium include: Science and technologies for cancer diagnostic and imaging techniques using nano particles as reporter platforms; bioanalytical nanotechnology for detection of biomarkers; nanoparticles for delivery of electromagnetic energy for hypothermia and thermal ablation of tumors; combination therapies (drug delivery and energy) using nanoparticles; and many more topics that relate to nanotechnology’s fight against cancer.
Scientists are limited in their ability to turn promising molecular discoveries into benefits for cancer patients. Nanotechnology can provide the technical power and tools that will enable those developing new diagnostics, therapeutics, and preventives to keep pace with today’s explosion in knowledge. This symposium creates a better understanding of how Nanotechnology can help with the challenge of fighting cancer and finding a cure for the future.
ABOUT NATIONAL CANCER INSTITUTE:
Towards the end of eliminating suffering and death from cancer, the National Cancer Institute is engaged in efforts to harness the power of nanotechnology to radically change the way we diagnose, image and treat cancer. NCI programs conducted over the past five years have supported research on novel nanodevices that may detect and pinpoint the location of cancer at its earliest stages, deliver anticancer drugs specifically to malignant cells, and determine in real-time if these drugs are effective in killing malignant cells. Fore more information, please visit nano.cancer.gov.
ABOUT NANO SCIENCE AND TECHNOLOGY INSITUTE:
The Nano Science and Technology Institute (NSTI) was created in 1997 and chartered with the promotion and integration of small technologies through education, technology and business development. The NSTI is the founder and manager of the world’s most comprehensive small technology scientific and business event, the annual Nanotechnology Conference and Trade Show (Nanotech). The NSTI provides technical, informational and business services to industrial and governmental organizations worldwide. Through its knowledge network, NSTI offers high-value services powered by a unique network of established high-level and long-term relationships with leaders in the nascent fields of nanotechnology. For more information about NSTI, please check out www.nsti.org.
212-941-8499 ext. 102